What is an appropriate threshold for HCQ dose reduction in quiescent SLE?
In a retrospective cohort of 381 patients with SLE in clinical remission, HCQ discontinuation and dose reductions of ≥75% were associated with an increased risk of flares
AC&R
doi.org/10.1002/acr.80…
In a retrospective cohort of 381 patients with SLE in clinical remission, HCQ discontinuation and dose reductions of ≥75% were associated with an increased risk of flares
AC&R
doi.org/10.1002/acr.80…